Growth Hormone and IGF-1 Growth hormone deficiency after TBI may contribute to fatigue, cognition, body composition and reduced quality of life
Ang II in healthy subjects and end-stage renal failure patients
Each of these peptides exists in two chemically distinct variants with different solubility, stability, and potentially different safety profiles
This creates a risk of: Contamination with undisclosed active substances Inaccurate labelling , meaning the product may contain more or less of a compound than stated Adulteration with pharmaceutical agents, including stimulants or diuretics, which have been identified in some weight loss supplements by the MHRA Even where peptide compounds are genuine, oral bioavailability is a fundamental pharmacological challenge
Additionally, certain red flag symptoms warrant immediate surgical evaluation if they are related to your spine condition: New or worsening bowel/bladder issues (incontinence, groin numbness)